These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5010790)

  • 1. [Blood coagulation and anticoagulation system indices following administration of heparin and antitubercular agents in patients with pulmonary tuberculosis].
    Gaĭbarov KK
    Probl Tuberk; 1972; 50(1):88-9. PubMed ID: 5010790
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of intravenous administration of 1st series preparations on blood coagulation in pulmonary and renal tuberculosis].
    Radkevich RA; Utkin VV; Gushanskiĭ AM
    Probl Tuberk; 1970; 48(7):31-5. PubMed ID: 5486078
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the blood coagulation in patients with pulmonary tuberculosis during treatment with preparations of the first order].
    Ivaniuta OM; Fomicheva NI; Chaban VM
    Vrach Delo; 1969 Aug; 8():38-9. PubMed ID: 5382482
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood histamine and heparin in restricted forms of pulmonary tuberculosis].
    Tvanovskiĭ VB
    Probl Tuberk; 1975; (5):53-7. PubMed ID: 1144346
    [No Abstract]   [Full Text] [Related]  

  • 5. [The concentration of prothdonamide in the blood of patients with pulmonary tuberculosis].
    Kalabukha AV
    Probl Tuberk; 1971; 49(12):26-9. PubMed ID: 5159683
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bacteriostatic activity of blood in pulmonary tuberculosis after administration of different drug combinations].
    Mkrtchian SV; Shmeleva VI; Utkin VV
    Probl Tuberk; 1976; 3():67-70. PubMed ID: 967863
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of heparin on the functional state of the cardiovascular system in active pulmonary tuberculosis].
    Pain GA; Meshcheriakov VG; Ushakova AG
    Probl Tuberk; 1980 Jan; (1):43-8. PubMed ID: 7367423
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood coagulation in patients with pulmonary tuberculosis in the course of treatment with tuberculostatic agents of the 1st and 2nd series].
    Chaban VM
    Vrach Delo; 1971 Nov; 11():75-8. PubMed ID: 5143286
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of intravenous therapy on blood circulation in patients with pulmonary tuberculosis in the preoperative period].
    Bryskovskiĭ NK
    Probl Tuberk; 1976; 3():35-8. PubMed ID: 967853
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic effects of four drug-combination therapy for previously untreated tuberculosis patients].
    Inagaki H; Yamamoto M; Ishioroshi Y; Hirose H; Yazaki M
    Kekkaku; 1968 Oct; 43(10):413-7. PubMed ID: 5709885
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intermittent chemotherapy in adolescents with tuberculosis].
    Firsova VA; Smirnova MN; Grigor'eva ZP; Orlova LS
    Probl Tuberk; 1983 Feb; (2):37-40. PubMed ID: 6844329
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood bacteriostatic activity in pulmonary tuberculosis patients undergoing treatment with drugs of the 1st and 2d series].
    Alekseevskaia KP
    Probl Tuberk; 1972; 50(6):48-52. PubMed ID: 5051126
    [No Abstract]   [Full Text] [Related]  

  • 13. [Aerosol therapy of pulmonary tuberculosis with a combination of trace elements and antitubercular agents].
    Kulik NM
    Probl Tuberk; 1975; (5):41-4. PubMed ID: 1144342
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum hexosamine, iron, and total iron-binding capacity during drug treatment of pulmonary tuberculosis.
    Tani P; Kokkola K
    Scand J Respir Dis Suppl; 1972; 80():143-51. PubMed ID: 4510911
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advances in chemotherapy of tuberculosis].
    Zierski M
    Gruzlica; 1972; 40(6):477-83. PubMed ID: 4559265
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on selection of drug regimens from the standpoint of total antimycobacterial activity of serum from patients under chemotherapy].
    Yamada Y
    Kekkaku; 1984 Oct; 59(10):550-3. PubMed ID: 6521168
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood coagulation state in destructive pulmonary tuberculosis patients under different methods of chemotherapy].
    Sagalovich VIa; Beresneva RE; Ivanova VB
    Probl Tuberk; 1981 May; (5):30-4. PubMed ID: 7255385
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combined treatment with capreomycin, ethambutol and rifampizin in chronic open pulmonary tuberculosis].
    Virchow C; Flemming J
    Beitr Klin Erforsch Tuberk Lungenkr; 1969; 140(1):40-6. PubMed ID: 5824389
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of lidase in the treatment of patients with fibro-cavernous pulmonary tuberculosis].
    Grigaliunas AP
    Probl Tuberk; 1974; (11):26-30. PubMed ID: 4449837
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinico-biochemical characteristics of adverse reactions to antibacterial drugs in patients with pulmonary tuberculosis].
    Kostina ZI; Shaposhnikov AM; Ivanovskiĭ VB
    Probl Tuberk; 1978 Aug; (8):38-41. PubMed ID: 704581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.